國立高雄大學圖資館 |

Language: English

Back

Bioinformatics of non small cell lun...

Babu M, Naresh.

Bioinformatics of non small cell lung cancer and the ras proto-oncogene

Record Type:	Electronic resources : Monograph/item
Title/Author:	Bioinformatics of non small cell lung cancer and the ras proto-oncogeneby Amita Kashyap, D. Bujamma, Naresh Babu M.
Author:	Kashyap, Amita.
other author:	Bujamma, D.
Published:	Singapore :Springer Singapore :2015.
Description:	vii, 72 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Bioinorganic chemistry.
Online resource:	http://dx.doi.org/10.1007/978-981-4585-08-8
ISBN:	9789814585088 (electronic bk.)

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
Kashyap, Amita.

Bioinformatics of non small cell lung cancer and the ras proto-oncogene[electronic resource] /by Amita Kashyap, D. Bujamma, Naresh Babu M. - Singapore :Springer Singapore :2015. - vii, 72 p. :ill. (some col.), digital ;24 cm. - Springer briefs in applied sciences and technology. Forensic and medical bioinformatics,2191-530X. - SpringerBriefs in applied sciences and technology.Forensic and medical bioinformatics..

Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References.

Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.

ISBN: 9789814585088 (electronic bk.)

Standard No.: 10.1007/978-981-4585-08-8doiSubjects--Topical Terms:

199910
Bioinorganic chemistry.

LC Class. No.: QP531

Dewey Class. No.: 572.51

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
LDR:02272nmm a2200325 a 4500 001 459841
003 DE-He213
005 20150603170235.0
006 m d
007 cr nn 008maaau
008 151110s2015 si s 0 eng d
020 $a 9789814585088 (electronic bk.)
020 $a 9789814585071 (paper)
024 7 $a 10.1007/978-981-4585-08-8 $2 doi
035 $a 978-981-4585-08-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QP531
072 7 $a UYQ $2 bicssc
072 7 $a COM004000 $2 bisacsh
082 0 4 $a 572.51 $2 23
090 $a QP531 $b .K19 2015
100 1 $a Kashyap, Amita. $3 710836
245 1 0 $a Bioinformatics of non small cell lung cancer and the ras proto-oncogene $h [electronic resource] / $c by Amita Kashyap, D. Bujamma, Naresh Babu M.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2015.
300 $a vii, 72 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Springer briefs in applied sciences and technology. Forensic and medical bioinformatics, $x 2191-530X
505 0 $a Introduction -- Review of Literature -- Materials and Methods (Tools and Databases) -- Flowchart -- Conclusion.-References.
520 $a Cancer is initiated by activation of oncogenes or inactivation of tumor suppressor genes. Mutations in the K-ras proto-oncogene are responsible for 10-30% of adenocarcinomas. Clinical Findings point to a wide variety of other cancers contributing to lung cancer incidence. Such a scenario makes identification of lung cancer difficult and thus identifying its mechanisms can contribute to the society. Identifying unique conserved patterns common to contributing proto-oncogenes may further be a boon to Pharmacogenomics and pharmacoinformatics. This calls for ab initio/de novo drug discovery that in turn will require a comprehensive in silico approach of Sequence, Domain, Phylogenetic and Structural analysis of the receptors, ligand screening and optimization and detailed Docking studies. This brief involves extensive role of the RAS subfamily that includes a set of proteins, which cause an over expression of cancer-causing genes like M-ras and initiate tumour formation in lungs. SNP Studies and Structure based drug discovery will also be undertaken.
650 0 $a Bioinorganic chemistry. $3 199910
650 0 $a Small cell lung cancer. $3 710839
650 1 4 $a Engineering. $3 210888
650 2 4 $a Computational Intelligence. $3 338479
650 2 4 $a Computational Biology/Bioinformatics. $3 274833
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Biomedical Engineering. $3 190464
650 2 4 $a Health Informatics. $3 274212
650 2 4 $a Appl.Mathematics/Computational Methods of Engineering. $3 273758
700 1 $a Bujamma, D. $3 710837
700 1 $a Babu M, Naresh. $3 710838
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in applied sciences and technology. $p Forensic and medical bioinformatics. $3 710368
856 4 0 $u http://dx.doi.org/10.1007/978-981-4585-08-8
950 $a Engineering (Springer-11647)